[HTML][HTML] Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
Aim Gastric cancer (GC) is a tumour entity with highly variant outcomes. Lymph node
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
HS Muti, C Röcken, HM Behrens… - European Journal of …, 2023 - ejcancer.com
Aim Gastric cancer (GC) is a tumour entity with highly variant outcomes. Lymph node
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
[PDF][PDF] Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
HS Muti, C Röcken, HM Behrens, C Maria - core.ac.uk
Aim: Gastric cancer (GC) is a tumor entity with highly variant outcomes. Lymph node
metastasis is a prognostically adverse biomarker. We hypothesized that GC primary tissue …
metastasis is a prognostically adverse biomarker. We hypothesized that GC primary tissue …
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
HS Muti, C Röcken, HM Behrens… - … Journal of Cancer, 2023 - cris.maastrichtuniversity.nl
Aim: Gastric cancer (GC) is a tumour entity with highly variant outcomes. Lymph node
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
HS Muti, C Röcken, HM Behrens… - European journal of … - pubmed.ncbi.nlm.nih.gov
Aim Gastric cancer (GC) is a tumour entity with highly variant outcomes. Lymph node
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study.
HS Muti, C Röcken, HM Behrens… - European Journal of …, 2023 - europepmc.org
Aim Gastric cancer (GC) is a tumour entity with highly variant outcomes. Lymph node
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
metastasis is a prognostically adverse biomarker. We hypothesised that GC primary tissue …
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
HS Muti, C Röcken, HM Behrens, CML Loeffler… - 2023 - opus.bibliothek.uni-augsburg.de
Aim Gastric cancer (GC) is a tumor entity with highly variant outcomes. Lymph node
metastasis is a prognostically adverse biomarker. We hypothesized that GC primary tissue …
metastasis is a prognostically adverse biomarker. We hypothesized that GC primary tissue …